Skip to main content
. Author manuscript; available in PMC: 2021 Mar 25.
Published in final edited form as: Nat Genet. 2020 Nov 23;52(12):1314–1332. doi: 10.1038/s41588-020-00713-x

Table 3. Newly identified independent BP-associated rare SNVs (MAF ≤ 0.01) at known loci in UK Biobank only.

Locus ID rsID Chr:Position Gene Info EA/OA Consequence Trait Unconditional SNV analysis FINEMAP output Ref
EAF β P-value Common SNVs in top configuration PP of n SNVs log10BF
5 rs41300100 1:11908146 NPPA 0.82 G/C 5’ UTR SBP 0.010 -0.10 4.70x10-21 rs2982373, rs5066, rs55892892 0.55 122.50 9,2,79
18 rs756799918 1:153464738 RN7SL44P 0.89 T/C intergenic SBP 0.0004 0.26 4.30x10-7 rs12030242 0.36 27.49 14
28 rs1805090 1:230840034 AGT NA T/G missense SBP 0.0025 0.11 6.80x10-8 rs3889728, rs2493135 0.79 26.23 8
28 rs539645495 1:230860071 RP11-99J16__A.2 0.97 G/A intron, non-coding transcript DBP 0.0024 0.13 3.20x10-9 rs2493135, rs3889728 0.83 30.97 8
33 rs56152193 2:20925891 LDAH 0.76 C/G intron PP 0.0006 -0.23 8.10x10-7 rs7255 0.36 17.95 17, 16
55 rs759606582 2:178325956 AGPS 0.96 G/A intron PP 0.0003 0.29 1.90x10-7 rs56726187 0.57 7.48 16
72 rs555934473 3:48899332 SLC25A20 0.74 T/G intron DBP 0.0012 -0.17 2.50x10-6 rs36022378, rs6442105, rs6787229 0.25 35.71 17, 16, 6, 11
73 rs76920163 3:53857055 CHDH 0.96 G/T intron SBP 0.0059 0.10 3.80x10-13 rs3821843, rs7340705, rs11707607 0.58 29.45 18, 16
rs144980716 3:53776904 CACNA1D 0.91 A/G intron PP 0.0065 0.07 2.60x10-8 rs36031811, rs77347777 0.57 18.42
85 rs547947160 3:141607335 ATP1B3 0.75 G/A intron PP 0.0008 0.20 6.00x10-6 rs6773662 0.54 7.040 13
86 rs545513277 3:143113550 SLC9A9 0.70 A/G intron PP 0.0006 -0.24 6.90x10-6 rs1470121 0.56 11.97 16
92 rs186525102 3:185539249 IGF2BP2 0.85 A/G intron SBP 0.0086 -0.06 6.70x10-7 rs4687477 0.56 8.08 17
94 rs111620813 4:8293193 HTRA3 NA A/G missense PP 0.0100 -0.05 2.00x10-6 rs28734123 0.53 12.54 18
132 rs181585444 5:129963509 AC005741.2 0.83 C/T intergenic DBP 0.0003 -0.30 3.80x10-6 rs274555 0.55 10.70 14, 13
137 rs546907130 6:8156072 EEF1E1 0.90 T/C intergenic SBP 0.0017 -0.14 1.90x10-7 rs3812163 0.70 8.57 16
141 rs72854120 6:39248533 KCNK17 0.91 C/T intergenic SBP 0.0073 -0.08 3.10x10-9 rs2561396 0.76 10.49 16
141 rs72854118 6:39248092 KCNK17 0.91 G/A intergenic DBP 0.0072 -0.07 2.70x10-7 rs1155349 0.85 11.12 16
164 rs138890991 7:40804309 SUGCT 0.94 C/T intron PP 0.0100 0.06 1.60x10-7 rs17171703 0.77 19.08 17
179 rs561912039 7:150682950 NOS3 0.74 T/C intergenic DBP 0.0017 -0.13 6.40x10-6 rs3793341, rs3918226, rs6464165, rs7788497, rs891511 0.34 81.75 9,14,10
183 rs570342886 8:23380012 SLC25A37 0.85 C/G intergenic DBP 0.0001 -0.48 9.80x10-7 rs7842120 0.58 15.74 16
190 rs201196388 8:95265263 GEM NA T/C splice donor PP 0.0005 0.26 2.40x10-9 rs2170363 0.34 31.80 16, 78
193 rs532252660 8:120587297 ENPP2 0.79 T/C intron DBP 0.0025 -0.11 4.10x10-7 rs7017173 0.81 26.53 6
193 rs181416549 8:120678125 ENPP2 0.84 A/G intron PP 0.0026 0.20 5.10x10-21 rs35362581, rs80309268 0.95 113.21 6
212 rs138765972 10:20554597 PLXDC2 0.94 C/T intron DBP 0.0075 -0.07 4.40x10-8 rs61841505 0.49 9.06 16
219 rs192036851 10:64085523 RP11-120C12.3 0.92 C/T intergenic SBP 0.0062 0.06 6.40x10-6 rs10995311 0.28 19.55 16, 13
234 rs150090666 11:14865399 PDE3B NA T/C stop gained DBP 0.0010 -0.16 5.20x10-7 rs11023147, rs2597194 0.55 12.93 16
242 rs139620213 11:61444612 DAGLA 0.89 T/C upstream gene PP 0.0019 0.11 5.90x10-6 rs2524299 0.48 6.64 15
246 rs540659338 11:89183302 NOX4 0.85 C/T intron PP 0.0027 -0.14 2.60x10-10 rs2289125, rs494144 0.62 58.09 17, 16
260 rs186600986 12:53769106 SP1 0.91 A/G upstream gene PP 0.0030 -0.09 1.10x10-6 rs73099903 0.48 12.91 19
266 rs137937061 12:111001886 PPTC7 0.74 A/G intron SBP 0.0048 -0.09 1.30x10-6 rs9739637, rs35160901, rs10849937, rs3184504 0.34 55.74 16, 4, 5
268 rs190870203 12:123997554 RILPL1 0.85 T/G intron PP 0.0020 0.12 1.70x10-7 rs4759375 0.72 9.50 13
270 rs541261920 13:30571753 RP11-629E24.2 0.79 G/C intergenic SBP 0.0005 0.24 9.20x10-6 rs7338758 0.54 10.09 16
281 rs149250178 14:100143685 HHIPL1 0.75 A/G 3’ UTR DBP 0.0004 -0.29 2.30x10-6 rs7151887 0.51 7.93 16
299 rs139491786 16:2086421 SLC9A3r2 NA T/C missense DBP 0.0068 -0.12 1.60x10-20 rs28590346, rs34165865, rs62036942, rs8061324 0.57 50.80 16
304 rs2234710 16:30907835 BCL7C 0.79 T/G upstream gene SBP 0.0075 -0.08 2.30x10-9 - 0.52 6.29 17, 16
304* rs148753960 16:31047822 STX4 0.89 T/C intron PP 0.0099 -0.07 1.80x10-9 rs7500719 0.42 12.21 17, 16
317 rs756906294 17:42323081 SLC4A1 0.73 T/C downstream gene PP 0.0030 0.01 8.30x10-6 rs66838809 0.27 18.94 17
322 rs16946721 17:61106371 TANC2 0.91 G/A intron DBP 0.0100 -0.07 1.40x10-11 rs1867624, rs4291 0.51 20.91 17, 16
333 rs55670943 19:11441374 RAB3D 0.87 C/T intron SBP 0.0085 -0.10 2.10x10-17 rs12976810, rs4804157, rs160838, rs167479 0.78 85.45 1315
346* rs149972827 20:30413439 MYLK2 0.98 A/G intron SBP 0.0036 -0.10 6.20x10-9 - 0.85 9.86 16
362 rs115089782 22:42329632 CENPM 0.93 T/C intergenic SBP 0.0001 0.53 4.20x10-6 rs139919 0.44 14.12 17, 13

FINEMAP25 was used to identify the most likely causal variants within the known loci (defined in Supplementary Table 1) using the BOLT-LMM results in UKBB, the full detailed listing of results is provided in Supplementary Table 8. Locus ID, the known locus identifier provided in Supplementary Table 1; Chr:Position, chromosome and physical position in Build 37; Info, imputation information score, NA indicates that the SNV was genotyped and not imputed; EA/OA, Effect allele and other allele, respectively; AA, amino acid change; Effect, predicted effect of the listed SNV; EAF, effect allele frequency; β, single variant effect estimate for the rare variant in the BOLT-LMM analysis; P-value, the single variant P-value from the mixed model in the BOLT-LMM analysis; PP of n SNVs, the posterior probability of the number of causal variants; Log10BF, log10 Bayes factor for the top configuration; Gene, nearest gene; Trait, blood pressure trait analyzed; Ref, reference of the first reports of association in the listed region.

rs540659338 identified in UK Biobank in NOX4 has r 2 = 1 in 1000G EUR with rs56061986 identified in the GCTA analysis in Table 4.

*

Variants at these loci are in LD with GCTA variants (Table 2): at locus 304, r 2 = 0.876 between rs148753960 and rs61738491; at locus 346, r 2 = 0.952 between rs149972827 and rs45499294.